Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ajo.2025.02.024 | DOI Listing |
Am J Ophthalmol
March 2025
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, INSERM-DGOS CIC1423, Paris, France; National Eye Institute, Bethesda, MD, USA; Department of Ophthalmology, The University of Pittsburg School of Medicine, Pittsburgh, PA, USA.
Kidney Int
December 2024
Department of Medicine, Division of Nephrology, Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA. Electronic address:
People with human immunodeficiency virus (HIV) are at risk for chronic kidney disease (CKD) due to HIV and antiretroviral therapy (ART) nephrotoxicity. Immediate ART initiation reduces mortality and is now the standard of care, but the long-term impact of prolonged ART exposure on CKD is unknown. To evaluate this, the Strategic Timing of Antiretroviral Treatment (START) trial randomized 4,684 ART-naïve adults with CD4 cell count > 500 cells/mm to immediate versus deferred ART.
View Article and Find Full Text PDFLancet Reg Health Eur
September 2024
National Cancer Institute, IRCCS Fondazione G.Pascale, Naples, Italy.
Respir Investig
November 2024
Department of Thoracic Surgery, The University of Tokyo Graduate School of Medicine, Tokyo, Japan. Electronic address:
Lancet Reg Health Eur
July 2024
National Cancer Institute, IRCCS Fondazione G.Pascale, Naples, Italy.
[This corrects the article DOI: 10.1016/j.lanepe.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!